Search

Your search keyword '"Tedeschi G"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Tedeschi G" Remove constraint Author: "Tedeschi G" Topic neurology (clinical) Remove constraint Topic: neurology (clinical)
145 results on '"Tedeschi G"'

Search Results

1. Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative

2. Signs and symptoms of COVID-19 in patients with multiple sclerosis

3. Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

4. HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine?

5. Current and emerging evidence-based treatment options in chronic migraine: A narrative review

6. The Italian multiple sclerosis register

7. MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis

8. Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

9. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis

10. The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS

11. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

12. Assessing response to interferon-β in a multicenter dataset of patients with MS

13. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

14. Genetic counselling in ALS: facts, uncertainties and clinical suggestions

15. Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study

16. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion

17. Reasons driving treatment modification in Parkinson's disease: Results from the cross-sectional phase of the REASON study

18. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

19. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

20. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients

21. Adherence to anti-Parkinson drug therapy in the 'REASON' sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the 'Morisky Medical Adherence Scale-8 items'

22. Migraine-specific quality of life questionnaire and relapse on medication overuse headache

23. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72

24. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

25. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation

26. Intracerebral Haemorrhage: An Attempt at Statistical Assessment for Operability

27. Transient occlusion of intracranial blood vessels

28. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

29. Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab

30. Opinion, knowledge, and clinical experience with functional neurological disorders among Italian neurologists: results from an online survey

31. Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis

32. Disability assessment using Google Maps

33. Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients

34. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis

35. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

36. Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail

37. Dementia care and COVID-19 pandemic: a necessary digital revolution

38. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension

39. Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

40. Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire

41. Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis

42. Development and Validation of Automated <scp>Magnetic Resonance</scp> Parkinsonism Index 2.0 to Distinguish <scp>Progressive Supranuclear Palsy‐Parkinsonism</scp> From <scp>Parkinson's Disease</scp>

43. Telemedicine application to headache: a critical review

44. The future of neurology after the COVID-19 pandemic according to neurology residents

45. Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set

46. Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study

47. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

48. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study

49. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability

50. Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project

Catalog

Books, media, physical & digital resources